Gastrointestinal Agents / therapeutic use*

Explore academic connections and research related to this keyword

334
Views
12
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Feagan BG;Schreiber S;Wolf DC;Axler JL;Kaviya A;James A;Curtis RI;Geransar P;Stallmach A;Ehehalt R;B...
2019 inflammatory bowel diseases 541 views
2
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis
Mosli MH;MacDonald JK;Bickston SJ;Behm BW;Tsoulis DJ;Cheng J;Khanna R;Feagan BG;;
2015 inflammatory bowel diseases 472 views
3
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
Sandborn WJ;Colombel JF;Panaccione R;Dulai PS;Rosario M;Cao C;Barocas M;Lasch K;;
2019 journal of crohn's & colitis 443 views
4
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
Feagan BG;Rubin DT;Danese S;Vermeire S;Abhyankar B;Sankoh S;James A;Smyth M;;
2017 clinical gastroenterology and hepatology : the off... 460 views
5
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Harbord M;Eliakim R;Bettenworth D;Karmiris K;Katsanos K;Kopylov U;Kucharzik T;Molnár T;Raine T;Sebas...
2017 journal of crohn's & colitis 718 views
6
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Rosario M;French JL;Dirks NL;Sankoh S;Parikh A;Yang H;Danese S;Colombel JF;Smyth M;Sandborn WJ;Feaga...
2017 journal of crohn's & colitis 596 views
7
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
Pineton de Chambrun G;Blanc P;Peyrin-Biroulet L;;
2016 expert review of gastroenterology & hepatology 415 views
8
Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice
Römkens TE;Gijsbers K;Kievit W;Hoentjen F;Drenth JP;;
2016 Journal of gastrointestinal and liver diseases : J... 347 views
9
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease
Feagan BG;Sandborn WJ;Baker JP;Cominelli F;Sutherland LR;Elson CO;Salzberg BA;Archambault A;Bernstei...
2005 alimentary pharmacology & therapeutics 489 views
10
Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC
Arijs I;De Hertogh G;Lemmens B;Van Lommel L;de Bruyn M;Vanhove W;Cleynen I;Machiels K;Ferrante M;Sch...
2018 Gut 426 views
11
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed
Sands BE;Feagan BG;Rutgeerts P;Colombel JF;Sandborn WJ;Sy R;D'Haens G;Ben-Horin S;Xu J;Rosario M;Fox...
2014 gastroenterology 485 views
12
Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial
Dai YC;Zheng L;Zhang YL;Chen X;Chen DL;Tang ZP;;
2017 Medicine 311 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis research support non-u.s. gov't adult female male Remission Induction Antibodies Monoclonal follow-up studies pmid:30365009